Development strategy of Paris based on combination of domestic patent and current resource application and development.
10.19540/j.cnki.cjcmm.2018.0008
- Author:
Fei-Ya ZHAO
1
;
Ai-En TAO
1
;
Cong-Long XIA
1
Author Information
1. Department of Pharmacy and Chemistry, Dali University， Dali 671000, China.
- Publication Type:Journal Article
- Keywords:
Paris;
application and development;
development strategy;
patent analysis;
resources
- MeSH:
Drug Development;
trends;
Drugs, Chinese Herbal;
pharmacology;
Medicine, Chinese Traditional;
Melanthiaceae;
chemistry;
Patents as Topic;
Plants, Medicinal;
chemistry
- From:
China Journal of Chinese Materia Medica
2018;43(2):404-409
- CountryChina
- Language:Chinese
-
Abstract:
Paris is a commonly used traditional Chinese medicine (TCM), and has antitumor, antibacterial, sedative, analgesic and hemostatic effects. It has been used as an ingredient of 81 Chinese patent medicines, with a wide application and large market demand. Based on the data retrieved from state Intellectual Property Office patent database, a comprehensive analysis was made on Paris patents, so as to explore the current features of Paris patents in the aspects of domestic patent output, development trend, technology field distribution, time dimension, technology growth rate and patent applicant, and reveal the development trend of China's Paris industry. In addition, based on the current Paris resource application and development, a sustainable, multi-channel and multi-level industrial development approach was built. According to the results, studies of Paris in China are at the rapid development period, with a good development trend. However, because wild Paris resources tend to be exhausted, the studies for artificial cultivation technology should be strengthened to promote the industrial development.
